{"entity":{"id":"senticell","kind":"company","name":"Senticell","aka":[],"tldr":"Senticell, a University of Pennsylvania spinout, is developing a blood test that reads genetic material carried on red blood cells, a source most liquid biopsies ignore, to find cancer mutations from a single blood draw.","summary":"Senticell is a molecular diagnostics company that grew out of research at the University of Pennsylvania and licenses the technology from it. Its platform analyses nucleic acids bound to red blood cells together with cell-free DNA, and the company says it can detect disease-specific RNA, cfDNA and protein biomarkers from one blood sample. It is led by physician-scientist Nilam Mangalmurti. Trade reports in September 2026 described an oversubscribed seed round approaching USD 7 million and two prospective studies at Penn Medicine enrolling about 300 patients with lung, pancreatic, head and neck and cervical cancers.","asOf":"2026-10-29","links":[{"label":"Official website","url":"https://senticell.bio/"},{"label":"About Senticell","url":"https://senticell.bio/about"},{"label":"BioBriefs: seed round, September 2026","url":"https://biobriefs.com/liquid-biopsy-startup-raises-seed"}],"tags":[],"related":[],"cancers":[],"sections":["diagnostics"],"technologies":["liquid-biopsy"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Founding year not stated. The company website gives a Princeton, New Jersey address; some trade reports place it in Philadelphia. The seed round and the Penn Medicine studies come from secondary reports (GenomeWeb, BioBriefs) rather than a primary release, so no funding row or cancer links are recorded. The company website describes disease detection in general rather than oncology alone."],"hq":"Princeton, NJ","country":"US","companyType":"diagnostics","website":"https://senticell.bio/","stage":"startup","investors":[],"funding":[]},"route":"/companies/senticell/","neighbours":{"section":[{"id":"diagnostics","kind":"section","name":"Diagnostics & Biomarkers","route":"/fronts/diagnostics/"}],"technology":[{"id":"liquid-biopsy","kind":"technology","name":"Liquid biopsy (ctDNA)","route":"/technologies/liquid-biopsy/"}]}}